Articles scientifiques

Temper the Specialist Nurses Heterogeneity in the Interest of Quality Practice and Mobility-18 EU Countries Study.

Auteurs : Decock N, Friganovic A, Kurtovic B, Oomen B, Crombez P, Willems C
Année : 2022
Journal : Healthcare (Basel)
Volume : 10

Suburethral implantation of autologous regenerative cells for female stress urinary incontinence management: Results of a pilot study.

Auteurs : Maene A, Deniz G, Bouland C, Lagneaux L, Philippart P, Buxant F
Année : 2022
Journal : Eur J Obstet Gynecol Reprod Biol
Volume : 278
Pages : 38-44

An Atypical Behavior of Metastatic Lung Disease in a Young Woman With Osteosarcoma: A Case Report.

Auteurs : Acquisto A, Duran Derijckere I, De Angelis R
Année : 2022
Journal : Cureus
Volume : 14
Pages : e21589

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

Auteurs : Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, Triulzi T, El-Abed S, Wang Y, Bajji M, Nuciforo P, Huober J, Ellard SL, Rimm DL, Gombos A, Daidone MG, Verderio P, Tagliabue E, Di Cosimo S, Iorio MV
Année : 2022
Journal : Cancer Med
Volume : 11
Pages : 332-339

Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?

Auteurs : Benkhaled S, Koshariuk O, Van Esch A, Remouchamps V
Année : 2022
Journal : Rep Pract Oncol Radiother
Volume : 27
Pages : 490-499

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progressio

Auteurs : Wildiers H, Meyskens T, Marréaud S, Lago LD, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Meulemans B, Sousa B, Poncet C, Brain E
Année : 2022
Journal : Breast
Volume : 64
Pages : 100-111

Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.

Auteurs : Schuster M, Zijlstra J, Casasnovas RO, Vermaat JSP, Kalakonda N, Goy A, Choquet S, Neste EVD, Hill B, Thieblemont C, Cavallo F, De la Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Follows G, Egyed M, Offner F, Vassilakopoulos T, Samal P, Ku M, Ma X, Corona K, Chamoun K, Shah J, Shacham S, Kauffman MG, Canales M, Maerevoet M
Année : 2022
Journal : Clin Lymphoma Myeloma Leuk
Volume : 22
Pages : 483-494

Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

Auteurs : Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Van Den Bergh RC, Peltier A, Ploussard G
Année : 2022
Journal : Minerva Urol Nephrol

Toward Targeted Therapies in Oesophageal Cancers: An Overview.

Auteurs : Bregni G, Beck B
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.

Auteurs : Agostinetto E, Jacobs F, Debien V, De Caluwé A, Pop CF, Catteau X, Aftimos P, de Azambuja E, Buisseret L
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Efficacy of pharmacologic treatment for treating gastrointestinal angiodysplasias-related bleeding: a systematic review and meta-analysis.

Auteurs : Gkolfakis P, Fostier R, Tziatzios G, Lazaridis N, Fernandez Y Viesca M, Facciorusso A, Despott E, Triantafyllou K, Devière J, Arvanitakis M
Année : 2022
Journal : Eur J Gastroenterol Hepatol
Volume : 34
Pages : 1021-1030

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.

Auteurs : Zijlstra JM, Follows G, Casasnovas RO, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Xu J, Corona K, Chamoun K, Shah J, Canales M, Maerevoet M
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib.

Auteurs : Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, van Cutsem E
Année : 2022
Journal : Crit Rev Oncol Hematol
Volume : 169
Pages : 103564

Impact of the first wave of the SARS-CoV-2/Covid-19 pandemic on digestive surgical activities: a Belgian National Survey.

Auteurs : Liberale G, Van Veer H, Lemaitre J, Duinslager M, Ysebaert D, De Roover A, de Gheldere C, Komen N
Année : 2022
Journal : Acta Chir Belg
Volume : 122
Pages : 233-239

Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides.

Auteurs : Li WB, Bouvier-Capely C, Saldarriaga Vargas C, Andersson M, Madas B
Année : 2022
Journal : Radiat Environ Biophys
Volume : 61
Pages : 579-596

Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.

Auteurs : Nader-Marta G, Debien V, Eiger D, Tsourti Z, Caparica R, Kassapian M, Napoleone S, Hultsch S, Korde L, Wang Y, Chumsri S, Pritchard KI, Untch M, Bellet-Ezquerra M, Dornelles Rosa D, Moreno-Aspitia A, Piccart M, Dafni U, de Azambuja E
Année : 2022
Journal : Br J Cancer
Volume : 127
Pages : 1799-1807

Psychological factors associated with clinical fear of cancer recurrence in breast cancer patients in the early survivorship period.

Auteurs : Waroquier P, Delevallez F, Razavi D, Merckaert I
Année : 2022
Journal : Psychooncology
Volume : 31
Pages : 1877-1885

Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals.

Auteurs : Prades J, Coll-Ortega C, Dal Lago L, Goffin K, Javor E, Lombardo C, de Munter J, Ponce J, Regge D, Salazar R, Valentini V, Borras JM
Année : 2022
Journal : BMJ Open
Volume : 12
Pages : e051181

The Managing Advanced Cancer Pain Together (MACPT) conversation tool: an evaluation of use in clinical practice.

Auteurs : Quinn B, Laurent S, Dargan S, Lapuente M, Lüftner D, Drudge-Coates L, Palma MD, Dal Lago L, Flynn J, Panter C, Seesaghur A
Année : 2022
Journal : Pain Manag
Volume : 12
Pages : 435-446

The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study.

Auteurs : Van Bockstal MR, Beniuga G, Craciun L, Creytens D, Dedeurwaerdere F, Delvenne P, Demetter P, De Wiest B, Dewinne K, Habran L, Pauwels P, Theate I, Vander Borght S, Van Der Steen K, Weynand B
Année : 2022
Journal : Pathobiology
Pages : 1-14